Project information

URGENT delivery of medicines to Ethiopia

Provide desperately needed financial and technical assistance to the Ethiopian Ministry of Health to deliver the single annual treatment for schistosomiasis (3.5 million tablets of praziquantel donated by WHO) to 1.5 million children and 6.8 million tablets against STH before the tablets expire

February 2013 - September 2013

Charity information: SCI (Schistosomiasis Control Initiative)

SCI (Schistosomiasis Control Initiative) logo
  • Need


    Ethiopia is one of the most heavily populated and infected (with schisto and STH) countries in Africa. WHO recognised the severity of the situation and donated drugs for treatment. Lack of funds for delivery has prevented millions of children receiving treatment to combat these diseases. If the drugs are not delivered soon then they will have to be destroyed. We hope that the distribution of these tablets will kick-start a 5 year national programme and have a lasting impact on child health.


    This project will provide the government of Ethiopia with the necessary technical and financial assistance required to distribute the donated tablets to their at-risk population. It will also provide funds to map the distribution of disease across the country so resources can be targeted most effectively, and will provide assistance for a stakeholders’ meeting to bring together all the relevant organisations involved in deworming in the country to help plan the ongoing national campaigns.

  • Aims

    Aim 1

    Ensure 3.5 mil tablets of praziquantel and 6.8 mil tablets of mebendazole reach those in need.


    » Provide technical expertise and financial support to ensure the drugs are delivered efficiently and effectively.

    Collect coverage data while treatment is being carried out showing how many people received treatment, when and where and how many tablets were used.

    Aim 2

    Assist the Ethiopian government to eliminate schisto as a major health risk to its population


    » Train local health workers, school teachers and laboratory technicians on the life cycle, diagnostic procedures and treatment of schistosomiasis.
    » Advocate to win political support within the (Federal and Regional) Ministries of Health and Education for the disease control measures.

    Post treatment, collect data to indicate the effect treatment has had on prevalence and intensity of schistosomiasis and STH in the areas selected for treatment.

    Aim 3

    Demonstrate the need for the WHO to continue and increase the donation of praziquantel to Ethiopia.


    » Monitor and evaluate the programme to ensure the government has evidence to prove the effectiveness of the treatment.
    » Bring together all the relevant partner organizations in a stakeholders meeting in Addis Ababa.

    Map the areas that did not receive treatment to quantify the need for further drug donations.

    Aim 4

    Ensure that the donated drugs are not wasted.


    » Provide technical expertise and financial support to ensure the drugs are delivered efficiently and effectively.

    Establishing locally trained staff who are able to successfully deliver the drugs.

    Aim 5

    Use this distribution to assist the government to start a National Schistosomiasis Control Programme


    » Advocate to win political support within the (Federal and Regional) Ministries of Health and Education for the disease control measures.
    » Monitor and evaluate the programme to ensure the government has evidence to prove the effectiveness of the treatment.
    » Map the distribution of schistosomiasis infection across the country.

    Create momentum in the Ethiopian Ministry of Health (both Federal and Regional) through demonstrable results.
    The WHO donate drugs to enable treatment the following year.

  • Impact


    - Improve knowledge and understanding of schistosomiasis at all levels – political, district and local.
    - Start the long process to reduce the prevalence and intensity of sickness due to schistosomiasis.
    Break the infection cycle of schistosomiasis thereby reducing prevalence between treatment rounds.
    Stop the development of chronic symptoms amongst the currently infected population.
    Improve Ethiopia’s drug delivery mechanism resulting in greater efficiency for subsequent rounds of treatment


    Lack of communication/collaboration between Federal and Regional Ministries of Health - extremely unlikely as they have all been working together to develop the countries National Schistosomiasis Control Programme.
    Disagreement as to how drugs are to be distributed amongst regions - by hosting a stakeholder meeting any issues will have a forum in which to resolve them.
    Not all drugs can be delivered in time due to lack of sufficient funds - we are confident we can raise the amount required.


    SCI has an established reporting system.
    Inception report – detailed outline of project
    Interim report post delivery of treatment e.g. number of treatments delivered, number of people treated per district and schedule for monitoring and evaluation of the programme.
    Final report

  • Budget

    Budget - Project Cost: £50,000

    Loading graph....
      Amount Heading Description
      £10,000 Advocacy & Sensitisation Advocacy and Community sensitisation to ensure the buy in of the target population.
      £10,000 Training Training of health workers and teachers
      £15,000 Distribution Transport and storage for distribution of drugs.
      £5,000 Training technicians Training of technicians for monitoring and evaluating success of project
      £10,000 Mapping Mapping of areas which will not receive treatment to establish further need and assistance required
  • Background


    Ethiopia has a population of around 84 mil people, 14 mil estimated to be under 15 years and approx. 65% enrolled in school. The population is very diverse, containing over 80 distinct ethnic groups: a Christian majority (63%), a large Islam minority (34%), and smaller numbers of African traditional and other religions. It has a very low urbanisation rate (approximately 15%) which increases the number of people exposed to schisto. Schisto and STH are thought to be endemic across the country.


    Of the 14 mil children (<16) the majority are considered at risk of schistosomiasis and in some schools the prevalence is extremely high. In this first round of the project 1.5 million children will receive treatment against schistosomiasis, and 6.8 million against STHs. One successful round of treatment will leverage many more drug donations and kick-start a national programme that will follow up with further treatments. An estimated 14 million treatments a year for up to 5 years would be ideal

  • Why Us?

    Why Us?

    SCI has delivered over 100 million treatments for schistosomiasis in 13 sub-Saharan countries since 2002, more than all other organisations put together. We have an excellent working relationship with the WHO Department of Control of Neglected Tropical in Geneva and have experience in all aspects of this highly specialised disease.

    Read more about the Charity running this project.


    SCI Director, Prof Alan Fenwick

    Prof Alan Fenwick will give his time free of charge. Advocacy at the highest level is his forte. He will lay the groundwork for this project.

    Dr Mike French (SCI Employee)

    Dr French is a researcher and programme manager at SCI. He has been heavily involved in the national programme in Yemen. He will oversee the project.

    Mr Meribo Kadu Is The NTD Focal Point Within The Ethiopian Federal Ministry Of Health

    Mr Kadu is responsible for integrating control of NTDs in the country and working with the regions to bring about effective and efficient programmes.

Neglected Tropical Diseases promote poverty


to treat a child for neglected tropical diseases